Literature DB >> 1174691

Elevated platelet count and megathrombocyte number in sickle cell anemia.

M L Freedman, S Karpatkin.   

Abstract

Eight adult patients with sickle cell anemia were followed over a 6-mo period. During this time all patients had elevated plateletcounts, 1.7-fold (mean, 438,398 +/- 86,223), and megathrombocyte numbers, 2.3-fold (mean, 79,535 +/- 38,907), during asymptomatic periods. These data are interpreted as suggesting that the elevated platelets and megathrombocytes in asymptomatic sickle cell patients result from lack of splenic sequestration. During three crises in two patients, both megathrombocyte number and platelet count fell significantly. It is speculated that platelets may be associated with the pathology in this disease. Platelet function studies performed during crises, therefore, must take into account the number of megathrombocytes.

Entities:  

Mesh:

Year:  1975        PMID: 1174691

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism.

Authors:  M W Kenny; A J George; J Stuart
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411

Review 2.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 3.  Myocardial infarction in sickle cell disease.

Authors:  Ishak A Mansi; Fred Rosner
Journal:  J Natl Med Assoc       Date:  2002-06       Impact factor: 1.798

4.  Morphological and functional platelet abnormalities in Berkeley sickle cell mice.

Authors:  Arun S Shet; Thomas J Hoffmann; Marketa Jirouskova; Christin A Janczak; Jacqueline R M Stevens; Adewole Adamson; Narla Mohandas; Elizabeth A Manci; Therese Cynober; Barry S Coller
Journal:  Blood Cells Mol Dis       Date:  2008-04-18       Impact factor: 3.039

5.  Advances in new drug therapies for the management of sickle cell disease.

Authors:  Kenneth I Ataga; Payal C Desai
Journal:  Expert Opin Orphan Drugs       Date:  2018-05-14       Impact factor: 0.694

6.  Hematological parameters in Ghanaian sickle cell disease patients.

Authors:  Charles Antwi-Boasiako; Ivy Ekem; Mubarak Abdul-Rahman; Frederika Sey; Alfred Doku; Bartholomew Dzudzor; Gifty B Dankwah; Kate Hagar Otu; John Ahenkorah; Robert Aryee
Journal:  J Blood Med       Date:  2018-10-31

7.  Hematological parameters in sickle cell anemia patients with and without priapism.

Authors:  Sagir G Ahmed; Umma A Ibrahim; Abba W Hassan
Journal:  Ann Saudi Med       Date:  2006 Nov-Dec       Impact factor: 1.526

8.  Expression of regulatory platelet microRNAs in patients with sickle cell disease.

Authors:  Shilpa Jain; Maria G Kapetanaki; Nalini Raghavachari; Kimberly Woodhouse; Guoying Yu; Suchitra Barge; Claudia Coronnello; Panayiotis V Benos; Gregory J Kato; Naftali Kaminski; Mark T Gladwin
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

9.  Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease.

Authors:  Ciprian B Anea; Matthew Lyon; Itia A Lee; Joyce N Gonzales; Amidat Adeyemi; Greer Falls; Abdullah Kutlar; Julia E Brittain
Journal:  Am J Hematol       Date:  2016-02       Impact factor: 10.047

10.  The Platelet Count and its Implications in Sickle Cell Disease Patients Admitted for Intensive Care.

Authors:  Durjoy K Shome; Ahmed Jaradat; Ahmed I Mahozi; Ali S Sinan; Ali Ebrahim; Mohammed Alrahim; Mohammad S Ebraheem; Eman J Mansoor; Kameela S Majed; Sheikh A Azeez Pasha
Journal:  Indian J Crit Care Med       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.